Company intelligence / Profile preview
Tyris Therapeutics
Paterna (Valencia area), Valencian Community, Spain
- Ownership
- Private
- Development stage
- Other
01
Overview
Tyris Therapeutics is developing non-viral DNA-based gene therapies using a proprietary DNA-optimization and delivery platform to treat rare genetic diseases, including orphan dermatologic indications, and is currently in the pre-clinical stage with no publicly disclosed clinical trial results.[1][2][3][5][6]
- Therapeutic areas
- Rare Diseases
- Modalities
- Gene therapyDNA therapyNon-viral gene therapy
- Industry
- Biotech
02
Drug pipeline
1 asset03
Partnerships
Almirall
Beyond the preview
Go deeper on Tyris Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Tyris Therapeutics.